Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,280
Total Claims
$326K
Drug Cost
441
Beneficiaries
$740
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-18%
Opioid rate vs peers
1.8% vs 2.2% avg
-48%
Cost per patient vs peers
$740 vs $1,411 avg
+24%
Brand preference vs peers
13.1% vs 10.6% avg
Opioid Prescribing
1.8%
Opioid Rate
207
Opioid Claims
$3,798
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,467 claims · $216K
Generic: 9,697 claims · $107K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 193 | $38K |
| Insulin Detemir | 148 | $25K |
| Linagliptin | 114 | $19K |
| Tirzepatide | 12 | $13K |
| Rivaroxaban | 72 | $12K |
| Empagliflozin | 30 | $11K |
| Insulin Aspart | 58 | $11K |
| Insulin Aspart | 69 | $6,237 |
| Rasagiline Mesylate | 39 | $5,369 |
| Pravastatin Sodium | 415 | $3,841 |
| Dapagliflozin Propanediol | 22 | $3,486 |
| Mirtazapine | 392 | $3,296 |
| Omeprazole | 361 | $3,273 |
| Atorvastatin Calcium | 360 | $3,166 |
| Memantine Hcl | 88 | $3,146 |
Prescribing Profile
Patient Profile
75
Avg Age
59%
Female
2.95
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data